Glenmark Reduces Price Of Fabiflu By 27%

Glenmark Pharmaceuticals announced that it has reduced price of anti-viral drug FabiFlu by 27% from Rs 103 to Rs 75 per tablet. FabiFlu is the brand name for the oral anti-viral drug Favipiravir which is being used to treat COVID-19 patients. The company has also announced the commencement of a Post Marketing Surveillance (PMS) study on FabiFlu to monitor the efficacy and safety of the drug in 1000 patients.